78,000 is the next stop ladies and gentlemen, come back down and bounce off that low volume node 65,338 grabbing liquidity for the wave higher. time i'm not putting a target on, I would say before end of year. conservative estimates.
78,000 is the next stop ladies and gentlemen, come back down and bounce off that low volume node 65,338 grabbing liquidity for the wave higher. time i'm not putting a target on, I would say before end of year. conservative estimates.
Lets go meme stock 3.0. 53.56 and LVN i think we should have some issues, not much until then. DJT FTW
6.80-7.19 extension targets 1, 8.34 area is the 100% extension. Could see by late November.
No timeframe on this one, since it looks like the algo has extended many times, $13.70 First Marco target.
Looks to me like 392.70 is a pretty great target before mid November. breakout.
Cisco breakout should hit 58.11 at least. before the apex of the ascending wedge. sitting right on the LVN for the range.
Bouncing off Low volume node on higher timeframe, picked up calls right before market close. Targets in image, breakout fibs.
KSS breaking out, looks to me like we can see 21.25 fib next week.
micro accumulation structure about to spring from the low volume node. This one is pretty clear to me, NFA,
IWM heading to $224, basically a certainty. aiming for options exp around nov 4 monday open, will sell majority there and rise the rest as a bonus. NOT FINANCIAL ADVISE.
Macro Consolidation wedge broken, riding the fib channel higher, wouldn't be surprised if we come down to an order block i've marked out for orders sitting (liquidity responsible for the break of structure) that then sends us to the breakout fib 145.40 area.
See if we can hit targets below. looks like we are trading topside of a LVN, Tested 5 min orderblock, iFVG, BPR. What i dont like is no red folder until another 1.5 hours. However, no reason for is to trade much higher IMO with no data for the the market to want to re evaluate us higher.
Neuberger Berman Group LLC recently acquired Tetra Technologies Inc., showing their belief in the company’s potential for growth, especially in the energy sector. Hedge fund interest in Tetra is stable, with 22 holders still invested, reflecting ongoing confidence in its performance. The company is also experiencing a breakout from a wedge pattern, with price...
Editas Medicine (NASDAQ: EDIT) is focused on developing CRISPR-based gene-editing technologies and has a solid pipeline for treating various genetic diseases, cancers, and autoimmune conditions. They've partnered with major players like Bristol Myers Squibb and Vertex Pharmaceuticals, boosting their credibility in the field. Editas also holds a strong patent...
Esperion Therapeutics (NASDAQ: ESPR), priced at $1.68 as of September 27, focuses on creating medications for cardiovascular and cardiometabolic diseases. They've launched products like NEXLETOL and NEXLIZET, which help lower LDL cholesterol in adults. Recently, 26 hedge funds held about $98.59 million in the company, with Millennium Management as the top...
Aemetis (NASDAQ: AMTX) is working on technologies to replace petroleum-based products with renewable fuels, but its stock has dropped over 50% in the last year due to ongoing losses. However, it might be turning a corner, as analysts expect it to become profitable within two years and project a 90% increase in sales this year to $354 million. An analyst recently...
Amazon (AMZN) recently broke down from an uptrend wedge pattern, signaling a potential shift in momentum. The latest earnings report revealed disappointing revenue growth, rising operational costs, and a slowdown in AWS, raising concerns about future profitability. $160 area target. The strikes in Iran and among port workers could hit Amazon pretty hard. If ports...